Clinical trial
Randomized Clinical Trial to Evaluate the Efficacy and Safety of Product CM9241GRU in Relieving Nasal Symptoms in Perennial Allergic Rhinitis
NCT06577077 is registered in ClinicalTrials.gov with Ache Laboratorios Farmaceuticos S.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Clinical Trial to Evaluate the Efficacy and Safety of Product CM9241GRU in Relieving Nasal Symptoms in Perennial Allergic Rhinitis
- Lead sponsor
- Ache Laboratorios Farmaceuticos S.A.
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- September 30, 2024
- Completion date
- August 31, 2025
- Enrollment
- 432 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.